1,272 results on '"Arbustini, Eloisa"'
Search Results
152. Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic
153. Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up
154. Myths to debunk: the non-compacted myocardium
155. Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry
156. Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects
157. The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study
158. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
159. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
160. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer
161. Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers
162. Nonbiodegradable Expanded Polytetrafluoroethylene-Covered Stent Implantation in Porcine Peripheral Arteries: Histologic Evaluation of Vascular Wall Response Compared with Uncoated Stents
163. The Aortic Root
164. In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung
165. Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases
166. Translational Bioinformatics: Challenges and Opportunities for Case-Based Reasoning and Decision Support
167. Sources of Error and Interpretation of Plaque Morphology by Optical Coherence Tomography
168. Genetics of Idiopathic Dilated Cardiomyopathy
169. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy
170. A novel mutation of the glomulin gene in an Italian family with autosomal dominant cutaneous glomuvenous malformations
171. Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2)
172. Prevalence and quantitative assessment of macrophages in coronary plaques
173. Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study
174. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
175. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry
176. A New Pathway Promotes Adaptation of Human Glioblastoma Cells to Glucose Starvation
177. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock
178. Hereditary muscle diseases and the heart: the cardiologist’s perspective
179. Correction: Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy
180. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
181. Cardiovascular manifestations in men and women carrying a FBN1 mutation
182. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis
183. The role of clinical and neuroimaging features in the diagnosis of CADASIL
184. From plaque biology to clinical setting
185. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy
186. Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy
187. POST-TRANSPLANT OUTCOME OF DILATED CARDIOMYOPATHY CAUSED BY DYSTROPHIN GENE DEFECTS: P-152
188. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy
189. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy
190. Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts
191. The new European definition of cardiomyopathies: which space for muscle dystrophies?
192. What do tachycardiomyopathy belong to?
193. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
194. Cranial fasciitis with exclusive intracranial extension in an 8-year-old girl
195. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
196. Additional file 1: of European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants
197. Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes
198. Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
199. Mechanisms of Disease: apoptosis in heart failure-seeing hope in death
200. Aneurysm Syndromes and TGF-(beta) Receptor Mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.